Breakthrough research in New Zealand offers hope for treating aggressive leukaemia

Researchers at University of Auckland in New Zealand are working on an innovative way to treat an aggressive blood cance...

June 13, 2024 | Thursday | News
Australia to invest $5 M over next 4 years to prevent rheumatic heart disease across Pacific

While in Geneva to advance Australia’s interests at the World Health Organization’s (WHO) World Health Assem...

June 11, 2024 | Tuesday | News
Novartis partners with Abu Dhabi govt to advance genomics research in oncology

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Me...

June 7, 2024 | Friday | News
Singapore's NUS Medicine researchers engineer bacteria for targeted chemotherapy delivery

Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy tissue and...

June 6, 2024 | Thursday | News
Singapore-Japan team finds common virus that triggers growth of nasopharyngeal cancer

Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...

June 6, 2024 | Thursday | News
Evolving Market Dynamics in Biopharma and Genomic Medicines

Precision medicine is becoming more prevalent, with pharmaceutical companies and healthcare regimen to develop highly ta...

June 5, 2024 | Wednesday | Opinion
Abu Dhabi government collaborates with Pfizer to advance research in sickle cell disease

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...

June 4, 2024 | Tuesday | News
Singapore study reveals surprising twist in how diabetes drugs help the heart

A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...

May 31, 2024 | Friday | News
OBiO Tech launches Clinical Evaluation and Translation Centre for rare diseases in China

OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...

May 30, 2024 | Thursday | News
Evotec and CHDI Extend 20-Year Collaboration to Advance Huntington’s Disease Therapeutics

Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...

May 30, 2024 | Thursday | News
Astatine to emerge as Japan-originated therapy for prostate cancer patients

A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...

May 28, 2024 | Tuesday | News
Singapore designs new genetic tool to investigate brain function and psychiatric disorders

Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...

May 24, 2024 | Friday | News
Singapore opens doors for new developments in cancer biomarker discovery

A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...

May 22, 2024 | Wednesday | News
Traverse the rapid evolution of AI in combating the pediatric myopia epidemic in Asia

The urgency to address the myopia epidemic among children has never been more pressing. Recent studies reveal an al...

May 21, 2024 | Tuesday | Opinion
Australia launches new specialist ophthalmic clinical trial facility

To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...

May 21, 2024 | Tuesday | News
Singapore's AI potential and prospects to emerge as a premier clinical trials hub

As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...

May 17, 2024 | Friday | Opinion
Achieving optimal therapeutic modalities for NCDs in the APMA region

The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...

May 16, 2024 | Thursday | Opinion
Singapore approves J&J's Bispecific Antibody treatment for Multiple Myeloma

Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...

May 15, 2024 | Wednesday | News